Premium
AC Immune SA (ACIU)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurod... AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Show more
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome ACI-24.060 was generally safe and well tolerated in individuals with Down syndrome with no serious...
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high...
AC Immune to Present at the Jefferies 2024 London Healthcare Conference Lausanne, Switzerland, November 13, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company...
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update ACI-7104.056 VacSYn Phase 2 trial in Parkinson’s disease (PD) on track to report interim safety and...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1447 | 5.32906124553 | 2.7153 | 3.0699 | 2.6 | 102695 | 2.68097365 | CS |
| 4 | -0.54 | -15.8823529412 | 3.4 | 3.41 | 2.6 | 130794 | 2.98757941 | CS |
| 12 | -0.64 | -18.2857142857 | 3.5 | 3.88 | 2.6 | 111826 | 3.14049217 | CS |
| 26 | -1.07 | -27.2264631043 | 3.93 | 4.26 | 2.6 | 129782 | 3.43615041 | CS |
| 52 | -1.94 | -40.4166666667 | 4.8 | 5.14 | 2.25 | 316493 | 3.42585961 | CS |
| 156 | -2.54 | -47.037037037 | 5.4 | 5.4 | 1.68 | 250495 | 3.29488098 | CS |
| 260 | -5.44 | -65.5421686747 | 8.3 | 14.89 | 1.68 | 431446 | 6.07505231 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
